Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide

Anticancer Research

Volumn 30, Issue 1, 2010, Pages 39-46

  Jacoby, Douglas B ^a   Dyskin, Evgeny ^b   Yalcin, Murat ^b   Kesavan, Kamala ^a   Dahlberg, William ^a   Ratliff, Judson ^a   Johnson, Eric W ^a   Mousa, Shaker A ^b  

^a TransMolecular Inc   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Angiogenesis; Chlorotoxin; Invasion; MMP 2; TM601

Indexed keywords

ANGIOGENIC FACTOR; BEVACIZUMAB; GELATINASE A; RANIBIZUMAB; SYNTHETIC PEPTIDE; TM601; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENDOTHELIUM CELL; FEMALE; GROWTH INHIBITION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; TUMOR GROWTH; UMBILICAL CORD;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DRUG SYNERGISM; ENDOTHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROTOXINS; SCORPION VENOMS;

EID: 77649248564     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. DeBin JA, Maggio JE and Strichartz GR: Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol 264: C361-369, 1993.
2. Gelly J-C, Gracy J, Kaas Q et al: The KNOTTIN website and database: a new information system dedicated to the knottin scaffold. Nucleic Acids Res 32: D156-D159, 2004.
3. Mamelak AN, Rosenfeld S, Bucholz R et al: Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol 24: 3644-3650, 2006.
4. Lyons SA, O'Neal J and Sontheimer H: Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia 39: 162-173, 2002.
5. Veiseh M, Gabikian P, Bahrami SB et al: Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intra-operative visualization of cancer foci. Cancer Res 67: 6882-6888, 2007.
6. Sun C, Veiseh O, Gunn J et al: In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 4: 372-379, 2008.
7. Veiseh O, Sun C, Fang C et al: Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 69: 6200-6207, 2009.
8. Meng X-X, Wan J-Q, Jing M et al: Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticles optical and magnetic resonance imaging contrast agents. Acta Pharm Sinica 28: 2019-2026, 2007.
9. Veiseh O, Kievit FM, Gunn JW et al: A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. Biomaterials 30: 649-657, 2009.
10. Mamelak AN and Jacoby DB: Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4: 175-186, 2007.
11. Deshane J, Garner CC and Sontheimer H: Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278: 4135-4144, 2003.
12. Sontheimer H: An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med 233: 779-791, 2008.
13. Mousa SS, Mousa SS and Mousa SA: Effect of resveratrol on angiogenesis and platelet/fibrin-accelerated tumor growth in the chick chorioallantoic membrane model. Nutr Cancer 52: 59-65, 2005.
14. Levina V, Su Y, Nolen B et al: Chemotherapeutic drugs and human tumor cells cytokine network. Int J Cancer 123: 2031-2040, 2008.
15. Lamszus K, Heese O and Westphal M: Angiogenesis-related growth factors in brain tumors. Cancer Treat Res 117: 169-190, 2004.
16. Veiseh O, Gunn JW, Kievit F et al: Inhibition of tumor cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small 5: 256-264, 2009.
17. Sun C, Fang C, Stephen Z et al: Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Nanomedicine 3: 495-505, 2008.